Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody

Molecular Neurodegeneration

Volumn 7, Issue 1, 2012, Pages

  Youmans, Katherine L ^a   Tai, Leon M ^a   Kanekiyo, Takahisa ^b   Stine, W Blaine ^c,f   Michon, Sara Claude ^d   Nwabuisi Heath, Evelyn ^a   Manelli, Arlene M ^c,f   Fu, Yifan ^e   Riordan, Sean ^e   Eimer, William A ^e   Binder, Lester ^e   Bu, Guojun ^b   Yu, Chunjiang ^a   Hartley, Dean M ^d   Ladu, Mary Jo ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f ABBOTT LABORATORIES   (United States)

Author keywords

3xTg; 5xFAD; A ; Alzheimer's disease; Antibody; APP; Intraneuronal; MOAB 2

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CATHEPSIN D; IMMUNOGLOBULIN G2B; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MOAB 2; UNCLASSIFIED DRUG; AMYLOID PRECURSOR PROTEIN; ANTIBODY;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BRAIN; CARBOXY TERMINAL SEQUENCE; CELL ORGANELLE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; TRANSGENIC MOUSE; WESTERN BLOTTING; AMYLOID PLAQUE; ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; BAGG ALBINO MOUSE; CELL CULTURE; CHEMISTRY; DISEASE MODEL; HUMAN; IMMUNOLOGY; METHODOLOGY; PATHOLOGY;

MUS; MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PLAQUE, AMYLOID;

EID: 84858220863     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-7-8     Document Type: Article

References (61)

1. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J, Am J Pathol 1999 155 853 862 10.1016/S0002-9440(10)65184-X 10487842 (Pubitemid 29426831)
2. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Tomic JL, Pensalfini A, Head E, Glabe CG, Neurobiol Dis 2009 35 352 358 10.1016/j.nbd.2009.05.024 19523517
3. Intraneuronal Abeta42 accumulation in human brain. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, et al. Am J Pathol 2000 156 15 20 10.1016/S0002-9440(10)64700-1 10623648 (Pubitemid 30644433)
4. The development of amyloid beta protein deposits in the aged brain. Thal DR, Capetillo-Zarate E, Del Tredici K, Braak H, Sci Aging Knowledge Environ 2006 2006 e1 10.1126/sageke.2006.6.re1 16525193
5. Accumulation of intraneuronal Abeta correlates with ApoE4 genotype. Christensen DZ, Schneider-Axmann T, Lucassen PJ, Bayer TA, Wirths O, Acta Neuropathol 2010 119 555 566 10.1007/s00401-010-0666-1 20217101
6. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Gouras GK, Almeida CG, Takahashi RH, Neurobiol Aging 2005 26 1235 1244 10.1016/j.neurobiolaging.2005.05.022 16023263 (Pubitemid 41338539)
7. Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Fernandez-Vizarra P, Fernandez AP, Castro-Blanco S, Serrano J, Bentura ML, Martinez-Murillo R, Martinez A, Rodrigo J, Histol Histopathol 2004 19 823 844 15168346 (Pubitemid 38855065)
8. Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex. D'Andrea MR, Nagele RG, Wang HY, Lee DH, Neurosci Lett 2002 333 163 166 10.1016/S0304- 3940(02)00875-3 12429373 (Pubitemid 35335768)
9. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH, Histopathology 2001 38 120 134 10.1046/j.1365-2559.2001. 01082.x 11207825 (Pubitemid 32193626)
10. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Busciglio J, Pelsman A, Wong C, Pigino G, Yuan M, Mori H, Yankner BA, Neuron 2002 33 677 688 10.1016/S0896-6273(02)00604-9 11879646 (Pubitemid 34219240)
11. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC, Arch Pathol Lab Med 2001 125 489 492 11260621 (Pubitemid 32291552)
12. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Grundke-Iqbal I, Iqbal K, George L, Tung YC, Kim KS, Wisniewski HM, Proc Natl Acad Sci USA 1989 86 2853 2857 10.1073/pnas.86.8.2853 2649895 (Pubitemid 19112638)
13. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K, EMBO J 1985 4 2757 2763 4065091
14. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Billings LM, Oddo S, Green KN, McGaugh JL, Laferla FM, Neuron 2005 45 675 688 10.1016/j.neuron.2005.01.040 15748844 (Pubitemid 40320703)
15. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, et al. Am J Pathol 2004 165 1289 1300 10.1016/S0002-9440(10) 63388-3 15466394 (Pubitemid 39297734)
16. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E, Acta Neuropathol 2010 119 523 541 10.1007/s00401-010-0679-9 20354705
17. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Lord A, Kalimo H, Eckman C, Zhang XQ, Lannfelt L, Nilsson LN, Neurobiol Aging 2006 27 67 77 10.1016/j.neurobiolaging.2004.12.007 16298242 (Pubitemid 41627951)
18. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. J Neurosci 2006 26 10129 10140 10.1523/JNEUROSCI.1202-06.2006 17021169 (Pubitemid 44527407)
19. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM, Neuron 2003 39 409 421 10.1016/S0896-6273(03)00434-3 12895417 (Pubitemid 36937044)
20. A dynamic relationship between intracellular and extracellular pools of Abeta. Oddo S, Caccamo A, Smith IF, Green KN, LaFerla FM, Am J Pathol 2006 168 184 194 10.2353/ajpath.2006.050593 16400022 (Pubitemid 43062572)
21. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK, Am J Pathol 2002 161 1869 1879 10.1016/S0002-9440(10)64463-X 12414533 (Pubitemid 35265544)
22. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G, Pradier L, Beyreuther K, Bayer TA, Neurosci Lett 2001 306 116 120 10.1016/S0304-3940(01)01876-6 11403971 (Pubitemid 32524311)
23. Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Wirths O, Multhaup G, Czech C, Feldmann N, Blanchard V, Tremp G, Beyreuther K, Pradier L, Bayer TA, Brain Pathol 2002 12 275 286 12146796 (Pubitemid 34743210)
24. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Christensen DZ, Kraus SL, Flohr A, Cotel MC, Wirths O, Bayer TA, Acta Neuropathol 2008 116 647 655 10.1007/s00401-008-0451-6 18974993
25. Intraneuronal APP, Not Free A{beta} Peptides in 3xTg-AD Mice: Implications for Tau versus A{beta}-Mediated Alzheimer Neurodegeneration. Winton MJ, Lee EB, Sun E, Wong MM, Leight S, Zhang B, Trojanowski JQ, Lee VM, J Neurosci 2011 31 7691 7699 10.1523/JNEUROSCI.6637-10.2011 21613482
26. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM, Neuron 2004 43 321 332 10.1016/j.neuron.2004. 07.003 15294141 (Pubitemid 39061125)
27. Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Abeta peptides in mouse models of Alzheimer's disease. Christensen DZ, Bayer TA, Wirths O, Brain Res 2009 1301 116 125 19751708
28. Intracellular amyloid-beta in Alzheimer's disease. LaFerla FM, Green KN, Oddo S, Nat Rev 2007 8 499 509 10.1038/nrn2168 (Pubitemid 46985362)
29. Development of Abeta terminal end-specific antibodies and sensitive ELISA for Abeta variant. Horikoshi Y, Sakaguchi G, Becker AG, Gray AJ, Duff K, Aisen PS, Yamaguchi H, Maeda M, Kinoshita N, Matsuoka Y, Biochem Biophys Res Commun 2004 319 733 737 10.1016/j.bbrc.2004.05.051 15184044 (Pubitemid 38739382)
30. Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain. Takeda K, Araki W, Akiyama H, Tabira T, FASEB J 2004 18 1755 1757 15364896 (Pubitemid 39561674)
31. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice. Philipson O, Lannfelt L, Nilsson LN, FEBS Lett 2009 583 3021 3026 10.1016/j.febslet.2009.08.009 19683527
32. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. Stine WB Jr, Dahlgren KN, Krafft GK, LaDu MJ, J Biol Chem 2003 278 11612 11622 10.1074/jbc.M210207200 12499373 (Pubitemid 36792723)
33. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ, J Biol Chem 2002 277 32046 32053 10.1074/jbc.M201750200 12058030 (Pubitemid 34969015)
34. Differential distribution of Alzheimer's amyloid precursor protein family variants in human sperm. Fardilha M, Vieira SI, Barros A, Sousa M, Da Cruz e Silva OA, Da Cruz e Silva EF, Ann N Y Acad Sci 2007 1096 196 206 10.1196/annals.1397.086 17405931 (Pubitemid 47092513)
35. Intracellular sAPP retention in response to Abeta is mapped to cytoskeleton-associated structures. Henriques AG, Vieira SI, Crespo-Lopez ME, Guiomar de Oliveira MA, da Cruz e Silva EF, da Cruz e Silva OA, J Neurosci Res 2009 87 1449 1461 10.1002/jnr.21959 19105196
36. Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. Lee EB, Leng LZ, Zhang B, Kwong L, Trojanowski JQ, Abel T, Lee VM, J Biol Chem 2006 281 4292 4299 10.1074/jbc.M511018200 16361260 (Pubitemid 43847859)
37. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, et al. Science 1999 286 735 741 10.1126/science.286.5440.735 10531052 (Pubitemid 29505878)
38. Amyloid-beta42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations. Youmans KL, Leung S, Zhang J, Maus E, Baysac K, Bu G, Vassar R, Yu C, LaDu MJ, J Neurosci Methods 2011 196 51 59 10.1016/j.jneumeth.2010.12.025 21219931
39. Intracellular accumulation of amyloid-Beta-a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Bayer TA, Wirths O, Front Aging Neurosci 2010 2 8 20552046
40. Alzheimer's disease: the amyloid cascade hypothesis. Hardy JA, Higgins GA, Science 1992 256 184 185 10.1126/science.1566067 1566067
41. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Haass C, Selkoe DJ, Nat Rev Mol Cell Biol 2007 8 101 112 10.1038/nrm2101 17245412 (Pubitemid 46432529)
42. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J, Selkoe DJ, Science 2002 297 353 356 10.1126/science.1072994 12130773 (Pubitemid 34790756)
43. Beta-amyloid monomers are neuroprotective. Giuffrida ML, Caraci F, Pignataro B, Cataldo S, De Bona P, Bruno V, Molinaro G, Pappalardo G, Messina A, Palmigiano A, et al. J Neurosci 2009 29 10582 10587 10.1523/JNEUROSCI.1736-09. 2009 19710311
44. A beta oligomers-a decade of discovery. Walsh DM, Selkoe DJ, J Neurochem 2007 101 1172 1184 10.1111/j.1471-4159.2006.04426.x 17286590 (Pubitemid 46718812)
45. Abeta oligomer-induced synapse degeneration in Alzheimer's disease. Wilcox KC, Lacor PN, Pitt J, Klein WL, Cell Mol Neurobiol 2011 31 939 948 10.1007/s10571-011-9691-4 21538118
46. Specificity and sensitivity of the Abeta oligomer ELISA. Klaver AC, Patrias LM, Finke JM, Loeffler DA, J Neurosci Methods 2011 195 249 254 10.1016/j.jneumeth.2010.12.001 21163305
47. Endogenous Abeta causes cell death via early tau hyperphosphorylation. Amadoro G, Corsetti V, Ciotti MT, Florenzano F, Capsoni S, Amato G, Calissano P, Neurobiol Aging 2011 32 969 990 10.1016/j.neurobiolaging.2009.06.005 19628305
48. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. Braak H, Thal DR, Ghebremedhin E, Del Tredici K, J Neuropathol Exp Neurol 2011 70 960 969 10.1097/NEN.0b013e318232a379 22002422
49. Targeting the amyloid-beta antibody in the brain tissue of a mouse model of Alzheimer's disease. McLean D, Cooke MJ, Wang Y, Fraser P, George-Hyslop PS, Shoichet MS, J Control Release 2011 PMID:22245684
50. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E, Acta Neuropathol 2010 119 523 541 10.1007/s00401-010-0679-9 20354705
51. Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Mochizuki A, Tamaoka A, Shimohata A, Komatsuzaki Y, Shoji S, Lancet 2000 355 42 43 10.1016/S0140-6736(99)04937-5 10615894 (Pubitemid 30072186)
52. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain. Aoki M, Volkmann I, Tjernberg LO, Winblad B, Bogdanovic N, Neuroreport 2008 19 1085 1089 10.1097/WNR. 0b013e328302c858 18596605
53. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ, Biochemistry 2000 39 10831 10839 10.1021/bi001048s 10978169
54. Transgenic Expression of Intraneuronal Abeta42 But Not Abeta40 Leads to Cellular Abeta Lesions, Degeneration, and Functional Impairment without Typical Alzheimer's Disease Pathology. Abramowski D, Rabe S, Upadhaya AR, Reichwald J, Danner S, Staab D, Capetillo-Zarate E, Yamaguchi H, Saido TC, Wiederhold KH, et al. J Neurosci 2012 32 1273 1283 10.1523/JNEUROSCI.4586-11.2012 22279212
55. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Wegiel J, Kuchna I, Nowicki K, Frackowiak J, Mazur-Kolecka B, Imaki H, Mehta PD, Silverman WP, Reisberg B, Deleon M, et al. Acta Neuropathol 2007 113 389 402 10.1007/s00401-006-0191-4 17237937 (Pubitemid 46421628)
56. Homing in on intracellular Abeta? Golde TE, Janus C, Neuron 2005 45 639 642 10.1016/j.neuron.2005.02.013 15748837 (Pubitemid 40320696)
57. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. Bittner T, Fuhrmann M, Burgold S, Ochs SM, Hoffmann N, Mitteregger G, Kretzschmar H, LaFerla FM, Herms J, PLoS One 2010 5 15477 10.1371/journal.pone.0015477 21103384
58. The distribution of tau in the mammalian central nervous system. Binder LI, Frankfurter A, Rebhun LI, J Cell Biol 1985 101 1371 1378 10.1083/jcb.101.4.1371 3930508 (Pubitemid 16203754)
59. Tau-66: evidence for a novel tau conformation in Alzheimer's disease. Ghoshal N, Garcia-Sierra F, Fu Y, Beckett LA, Mufson EJ, Kuret J, Berry RW, Binder LI, J Neurochem 2001 77 1372 1385 10.1046/j.1471-4159.2001.00346.x 11389188 (Pubitemid 32523690)
60. Identification of the intermediate filament-associated protein gyronemin as filamin. Implications for a novel mechanism of cytoskeletal interaction. Brown KD, Binder LI, J Cell Sci 1992 102 19 30 1500439
61. Conformational Abs recognizing a generic amyloid fibril epitope. O'Nuallain B, Wetzel R, Proc Natl Acad Sci USA 2002 99 1485 1490 10.1073/pnas.022662599 11818542 (Pubitemid 34136519)